News

Deal Announcements

Proteon Therapeutics Raises $12 Million Second Round

Tuesday, June 2, 2009 5:49:00 AM PDT | VentureDeal Staff
Waltham, Massachusetts  --  Biotechnology company Proteon Therapeutics has received $12 million in its second round of venture capital financing.

Proteon is developing what it calls "PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring."

Bessemer Venture Partners and Devon Park BioVentures made the investment. The company did not disclose how the funding proceeds would be used.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1